Tilray Inc. (TLRY) saw its shares plummet 5.20% during intraday trading on Thursday, reversing earlier gains as the market digested details of President Donald Trump's executive order on marijuana reclassification.
The drop followed clarifications from senior administration officials that the order would not change criminal penalties or recreational use access under federal law, nor would it recognize sufficient medical evidence for marijuana. This dashed hopes of a significant regulatory easing, leading to a sell-off in cannabis stocks like Tilray.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments